Standard InChI: InChI=1S/C25H20N6O3S/c1-14-30-31-20(34-14)12-15-6-8-17(9-7-15)23(33)29-24-21(22(26)32)28-25(35-24)27-19-11-10-16-4-2-3-5-18(16)13-19/h2-11,13H,12H2,1H3,(H2,26,32)(H,27,28)(H,29,33)
2.McDermott, Ultan U and 24 more authors. 2007-12-11 Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. [PMID:18077425]
3.Zarrinkar, Patrick P PP and 15 more authors. 2009-10-01 AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). [PMID:19654408]
4.Klaeger, Susan S and 47 more authors. 2017-12-01 The target landscape of clinical kinase drugs. [PMID:29191878]
5.Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048]
6.Read, Jon J and 19 more authors. 2019-08-01 Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase. [PMID:31153805]
7.Nair, Satheesh and 39 more authors. 2020-07-09 Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. [PMID:32676146]